Search

everythinglearnresearchcommunity

for

Search:↓

Pro-IGF-II improves muscle repair in old mice.

The document concludes that inhalation of oxygen and sumatriptan injections are primary for cluster headaches, indomethacin for paroxysmal hemicrania, and lidocaine and lamotrigine for SUNCT, but SUNCT often resists treatment.

Polydeoxyribonucleotide (PDRN) may help lighten skin and treat hyperpigmentation.

Personalized treatment plans are important for people with alopecia areata.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Men with advanced liver disease and high oestrone and low testosterone levels have worse health outcomes.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

Different treatments for alopecia areata have unpredictable results and varying success rates.

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

A woman with severe angioedema improved significantly after treatment with rituximab.

The document concludes that there are no reliable treatments for frontal fibrosing alopecia, with only temporary benefits from current options.

Nandrolone and oxandrolone could help treat male health issues like muscle loss and low testosterone.

The article compares different products for rejuvenating the upper part of the face.

High doses of minoxidil can harm marmoset hearts and kidneys, possibly affecting humans similarly.

The document concludes that various cosmetic and drug treatments are available for hirsutism, and some new drugs show promise.

A low-starch/low-dairy diet may help overweight women with PCOS lose weight and improve metabolism, but more research is needed.

Gene therapy shows promise for enhancing physical traits but faces ethical, safety, and regulatory challenges.

Vitamin D and estrogen may help protect heart and kidney health, and maintaining sufficient vitamin D levels could be especially beneficial for African Americans, postmenopausal women, and people with chronic kidney disease.

mTORC1 signaling needed for quick hair follicle recovery after radiation damage.

Nandrolone might increase muscle mass with fewer side effects than testosterone but could cause erectile dysfunction and needs more research.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Estrogens are key for bone growth spurts in both boys and girls and affect growth into adulthood.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Immunizing goats against melatonin can temporarily change their cashmere growth cycles and increase fleece production.

The document concludes that the hCG protocol may help in obesity treatment and could be scientifically justified, but more research is needed.

Transfollicular drug delivery is promising but needs more research to improve and understand it better.